Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients

Measurable residual disease (MRD) is the most powerful independent predictor of risk of relapse and long-term survival in adults and children with acute lymphoblastic leukemia (ALL). For almost all patients with ALL there is a reliable method to evaluate MRD, which can be done using multi-color flow...

Descripción completa

Detalles Bibliográficos
Autores principales: Saygin, Caner, Cannova, Joseph, Stock, Wendy, Muffly, Lori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Review Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713546/
https://www.ncbi.nlm.nih.gov/pubmed/36453516
http://dx.doi.org/10.3324/haematol.2022.280638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713546/
https://www.ncbi.nlm.nih.gov/pubmed/36453516
http://dx.doi.org/10.3324/haematol.2022.280638

Ejemplares similares